Table 1. Open in new tab Cohort and... | Oxford Academic

Table 1.

Open in new tab

Cohort and prevalence overview

Cohort	Total sample size	Apnea GWAS cases	Apnea GWAS controls	Snoring GWAS cases	Snoring GWAS controls
UK-Biobank	408 317	7902	248 112	152 303	256 014
Finngen	66 216	9096	57 120	4270	61 946
Partners Biobank	20 047	3102	16 945	4175	15 872
CLSA	18 427	3391	9615	6852	10 736
AGDS	10 359	1517	5838	4450	5907
Total	523 366	25 008	337 630	172 050	350 475

Cohort	Total sample size	Apnea GWAS cases	Apnea GWAS controls	Snoring GWAS cases	Snoring GWAS controls
UK-Biobank	408 317	7902	248 112	152 303	256 014
Finngen	66 216	9096	57 120	4270	61 946
Partners Biobank	20 047	3102	16 945	4175	15 872
CLSA	18 427	3391	9615	6852	10 736
AGDS	10 359	1517	5838	4450	5907
Total	523 366	25 008	337 630	172 050	350 475

GWAS cases and controls correspond to participants passing quality control as described in the methods.

Table 1.

Open in new tab

Cohort and prevalence overview

Cohort	Total sample size	Apnea GWAS cases	Apnea GWAS controls	Snoring GWAS cases	Snoring GWAS controls
UK-Biobank	408 317	7902	248 112	152 303	256 014
Finngen	66 216	9096	57 120	4270	61 946
Partners Biobank	20 047	3102	16 945	4175	15 872
CLSA	18 427	3391	9615	6852	10 736
AGDS	10 359	1517	5838	4450	5907
Total	523 366	25 008	337 630	172 050	350 475

Cohort	Total sample size	Apnea GWAS cases	Apnea GWAS controls	Snoring GWAS cases	Snoring GWAS controls
UK-Biobank	408 317	7902	248 112	152 303	256 014
Finngen	66 216	9096	57 120	4270	61 946
Partners Biobank	20 047	3102	16 945	4175	15 872
CLSA	18 427	3391	9615	6852	10 736
AGDS	10 359	1517	5838	4450	5907
Total	523 366	25 008	337 630	172 050	350 475

GWAS cases and controls correspond to participants passing quality control as described in the methods.